 12% to 15% of them are migraine patients. And I would say better than 90% of them got wonderful relief. All right, now I want to talk to you about this breaking publication that just came out through McCullough. This is very, very interesting. It's the International Journal of Vaccine Theory, Practice, and Research, another very important article.